UnknownPhase 4NCT06035055

Ceftolozane/Tazobactam Continuous Infusion for Infective Exacerbations of Cystic Fibrosis and Bronchiectasis

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sunshine Coast Hospital and Health Service
Principal Investigator
Julia J Bashford, BSc, MBBS
Sunshine Coast University Hospital
Intervention
Ceftolozane/tazobactam(drug)
Enrollment
30 enrolled
Eligibility
18 years · All sexes
Timeline
20232024

Collaborators

The Prince Charles Hospital · Mater

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06035055 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis

← Back to all trials